Literature DB >> 17048631

[Pharmacological evaluation of baicalin and jasminoidin and their combination on focal cerebral ischemia-reperfusion injury].

Zhan-jun Zhang1, Li-ya Wang, Zhong Wang, Peng-tao Li, Yong-yan Wang.   

Abstract

OBJECTIVE: To elucidate the therapeutic effect and the influence on PI3K-Akt-PKB-BAD-CREB-PCREB pathway in focal cerebral ischemia rat responses before and after treatment with baicalin and jasminoidin given alone or in combination.
METHOD: Rat model of ischemia reperfusion was established with thread. Generally accepted methods were used, including TTC staining, behavior test, as well as micro and ultra microscopy which can dynamically and accurately monitor pathological and physiological changes after cerebral ischemia on earlier period, to evaluate the brain injury induced by ischemia and the attenuations by the drugs. The difference of PI3K-Akt-PKB-BAD-CREB-PCREB expression was detected by western-blot technology. RESULT AND
CONCLUSION: The combination of baicalin and jasminoidin composition can be potential neuroprotective agent. TTC staining technology combined with behavior grade and ultrmicro-structure observation on brain tissue is effective method to evaluate protective agent, which is related to signal transduction PI3K-Akt-PKB-BAD-CREB-PCREB pathway. The results provide benofical basis for revealing the complex of therapeutic mechanism of traditional Chinese medicine Qingkai Ling (QKL).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048631

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  5 in total

1.  Variations in target gene expression and pathway profiles in the mouse hippocampus following treatment with different effective compounds for ischemia-reperfusion injury.

Authors:  Yinying Chen; Caixiu Zhou; Yanan Yu; Jun Liu; Zhiwei Jing; Aiping Lv; Fanyun Meng; Zhong Wang; Yongyan Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-24       Impact factor: 3.000

2.  Convergent and divergent pathways decoding hierarchical additive mechanisms in treating cerebral ischemia-reperfusion injury.

Authors:  Ying-Ying Zhang; Hai-Xia Li; Yin-Ying Chen; Hong Fang; Ya-Nan Yu; Jun Liu; Zhi-Wei Jing; Zhong Wang; Yong-Yan Wang
Journal:  CNS Neurosci Ther       Date:  2013-12-19       Impact factor: 5.243

3.  Neuroprotective effect of baicalin in a rat model of permanent focal cerebral ischemia.

Authors:  Xian-Kun Tu; Wei-Zhong Yang; Song-Sheng Shi; Chun-Hua Wang; Chun-Mei Chen
Journal:  Neurochem Res       Date:  2009-03-18       Impact factor: 3.996

4.  Exploratory Pharmacokinetics of Geniposide in Rat Model of Cerebral Ischemia Orally Administered with or without Baicalin and/or Berberine.

Authors:  Linmei Pan; Wenzhe Wang; Feiyan Shi; Jing Zhou; Meng Zhang; Huaxu Zhu; Mingfei Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-03       Impact factor: 2.629

5.  Quantitative Identification of Compound-Dependent On-Modules and Differential Allosteric Modules From Homologous Ischemic Networks.

Authors:  B Li; J Liu; Y Y Zhang; P Q Wang; Y N Yu; R X Kang; H L Wu; X X Zhang; Z Wang; Y Y Wang
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.